Ignite Creation Date:
2025-12-25 @ 2:37 AM
Ignite Modification Date:
2026-05-11 @ 3:36 AM
Study NCT ID:
NCT00317434
Status:
TERMINATED
Last Update Posted:
2009-12-15
First Post:
2006-04-20
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Maximum Tolerated Dose of Lapatinib When Given With Carboplatin for Recurrent Ovarian Cancer
Sponsor:
University of Alabama at Birmingham
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
UAB 0538 - F051025014
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Ronald D. Alvarez, M.D. / Director, Professor - Gynecologic Oncology
Old Organization:
University of Alabama at Birmingham
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |